Axis Small Cap Fund
The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity & equity related instruments of small cap companies.
Growthvine rating: 3/5 — ranked #11 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹108.79 (as of 2026-10-22) |
|---|
| AUM | ₹30,678 Cr |
|---|
| Expense ratio | 1.35% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Mayank Hyanki |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 14.09% |
|---|
| Sharpe ratio | 0.52 |
|---|
| Standard deviation | 16.99% |
|---|
| Max drawdown | −34.78% |
|---|
| Alpha | 2.55 |
|---|
| Beta | 0.76 |
|---|
Over 5 years, captured 76.9% of NIFTY Smallcap 250's upside and 63.7% of its downside.
Market cap allocation
| Large cap | 7.0% |
|---|
| Mid cap | 10.4% |
|---|
| Small cap | 82.6% |
|---|
Concentration
| Top 5 holdings | 10.8% |
|---|
| Top 10 holdings | 18.7% |
|---|
| Total holdings | 127 |
|---|
| Index overlap | 32.4% |
|---|
| Active share | 67.6% |
|---|
Top holdings
- Clearing Corporation of India Ltd — 7.1%
- Krishna Institute of Medical Sciences Limited — 2.5%
- Torrent Pharmaceuticals Ltd. — 2.3%
- CCL Products (India) Ltd. — 2.2%
- City Union Bank Ltd — 1.9%
- Sansera Engineering Limited — 1.9%
- Sai Life Sciences Limited — 1.8%
- Clearing Corporation of India Ltd — 1.6%
- Brigade Enterprises Limited — 1.5%
- Avalon Technologies Limited — 1.5%
Top sectors
- Industrial Products — 11.7%
- Banking & Financial — 10.5%
- Cash — 9.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 3.8% | Q3 | #20 of 34 |
| 2025 | −2.0% | Q1 (Top) | #8 of 30 |
| 2024 | 25.0% | Q3 | #15 of 28 |
| 2023 | 34.0% | Q4 (Bottom) | #20 of 24 |
| 2022 | 2.6% | Q2 | #9 of 22 |